CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC. et al > Summary
Court Case Number 2:20-cv-02614
Filing Date Mar 10, 2020
Termination Date Apr 27, 2020
Court New Jersey District Court
Status Dismissed - Other
JudgesEsther Salas, Michael A. Hammer
Plaintiff
Defendant
Plaintiff Attorneys
9Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Defendant Attorneys
9Teva Pharmaceuticals
Attorney Name: Christopher T. Jagoe
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Joseph L. Linares
Walsh Pizzi O’Reilly Falanga LLP
Teva Pharmaceuticals
Attorney Name: Eleonore Ofosu-Antwi
Walsh Pizzi O’Reilly Falanga LLP
Teva Pharmaceuticals
Attorney Name: Liza M. Walsh
Walsh Pizzi O’Reilly Falanga LLP
Teva Pharmaceuticals
Attorney Name: Kristen P. L. Reichenbach
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Jeanna M. Wacker
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Mark C. McLennan
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Thomas F. Fleming
Kirkland & Ellis
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10555939 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Feb 11, 2020 |
